FAIRFIELD, BUSH & CO. Nektar Therapeutics Transaction History

FAIRFIELD, BUSH & CO. portfolio value:

$0
portfolio value

FAIRFIELD, BUSH & CO. quarter portfolio value change:

-15.79%
quarter

Nektar Therapeutics 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -200 shares -1K $3.2 0
Q2 2022 share 0.00% 0 shares 0 $3.8 200
Q1 2022 share Increase 0.00% 200 shares 1K $5.39 200
Q2 2020 share Decrease -100.00% -12.2K shares -218K $23.16 0
Q1 2020 share Decrease -3.17% -400 shares -54K $17.85 12.2K
Q4 2019 share Decrease -3.82% -500 shares 33K $21.59 12.6K
Q3 2019 share Decrease -7.09% -1K shares -263K $18.22 13.1K
Q2 2019 share 0.00% 0 shares 28K $35.58 14.1K
Q1 2019 share Increase +17.50% 2.1K shares 80K $33.6 14.1K
Q4 2018 share 0.00% 0 shares -338K $32.87 12K
Q3 2018 share 0.00% 0 shares 146K $60.96 12K
Q2 2018 share 0.00% 0 shares -689K $48.83 12K
Q1 2018 share 0.00% 0 shares 558K $106.26 12K
Q4 2017 share 0.00% 0 shares 429K $59.72 12K
Q3 2017 share Increase 0.00% 12K shares 288K $24 12K